# US 2015/0307829 A1 · Mobile facility for preparing and distributing cell-based medicinal products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0307829 A1
- Document ID: US20150307829A1
- Status: Published application
- Kind: A1
- Application number: 14/670,019
- Filed: 2015-03-26
- Published: 2015-10-29
- Earliest claimed: 2012-09-28
- Assignees: Promethera Biosciences S.A./N.V.
- Applicants: Promethera Biosciences
- Inventors: Claude Dedry; Philippe Ducarme; Eric Halioua
- Web page: https://patentgrep.com/patent/US20150307829A1

## CPC

- C12M 23/52: {Mobile; Means for transporting the apparatus (transportable laboratories B01L1/52)}
- B01J 19/004: {Multifunctional apparatus for automatic manufacturing of various chemical products (sequential reactions B01J19/0046)}
- B62D 65/02: Joining sub-units or components to, or positioning sub-units or components with respect to, body shell or other sub-units or components
- C12M 23/44: {Multiple separable units; Modules}
- C12M 37/00: {Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination (C12M23/38 takes precedence; filtration in general and filters per se B01D24/00-B01D41/00; autoclaves B01J3/04; treatment of microorganisms with electrical or wave energy C12N13/00)}
- C12M 41/18: {Heat exchange systems, e.g. heat jackets or outer envelopes}
- B01J 2219/0002: Plants assembled from modules joined together
- B01L 99/00: Subject matter not provided for in other groups of this subclass
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B62D: MOTOR VEHICLES; TRAILERS (steering, or guiding on a desired track, of agricultural machines or implements A01B69/00; wheels, castors, axles, increasing wheel adhesion B60B; vehicle tyres, tyre inflation or tyre changing B60C; connections between vehicles of a train or the like B60D; vehicles for use on rail and road, amphibious or convertible vehicles B60F; suspension arrangements B60G; heating, cooling, ventilating or other air treating devices B60H; windows, windscreens, non-fixed roofs, doors or similar devices, protective coverings for vehicles not in use B60J; propulsion plant arrangements, auxiliary drives, transmissions, controls, instrumentation or dashboards B60K; electric equipment or propulsion of electrically-propelled vehicles B60L; power supply for electrically-propelled vehicles B60M; passenger accommodation not otherwise provided for B60N; adaptations for load transportation or to carry special loads or objects B60P; arrangement of signalling or lighting devices, the mounting or supporting thereof or circuits therefor, for vehicles in general B60Q; vehicles, vehicle fittings or vehicle parts not otherwise provided for B60R; servicing, cleaning, repairing, supporting, lifting, or manoeuvring, not otherwise provided for, B60S; brake arrangements, brake control systems or parts thereof B60T; air-cushion vehicles B60V; motor-cycles, accessories therefor B62J, B62K; testing of vehicles G01M)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

Example methods, apparatus and system are disclosed relating to a facility for formulating Cell-Based Medicinal Products (CBMPs) in a site where the facility is moved and CBMP formulations are administered. An example facility includes a unitary structure that is assembled together with a vehicle and that houses the working areas and equipment allowing operators to store, count, test, sample, formulate, and/or package CBMPs according to Good Manufacturing Practices. The teachings of the present disclosure relate to a method of providing formulations of a Cell-Based Medicinal Product in sites where the formulations are administered to patients, and from where the facility may be quickly relocated.

## Claims

### Claim 1

A facility for formulating a Cell-Based Medicinal Product comprising:
a first unit that is a working space to allow operators to at least one of store, count, test, sample, formulate, or package cell preparation and produce a Cell-Based Medicinal Product formulation according to Good Manufacturing Practices;
a second unit adjacent to and communicatively coupled the first unit to allow operators to access to the first unit, to store equipment and materials, to prepare themselves before and after accessing the first unit, and to bring Cell-Based Medicinal Product preparations, the equipment, and the materials in and out of the first unit;
a third unit adjacent to the first unit, the third unit to house equipment for exchanging of at least one of electric power, air, or data with one or more of the first unit, the second unit or a fourth unit; and
the fourth unit that includes a vehicle to transport a unitary structure comprising the first unit, the second unit, and the third unit.

### Claim 2 (depends on 1)

The facility of claim 1, wherein the first unit comprises:
a first working area equipped with a vertical laminar air flow coupled to the third unit with one or more instruments for at least one of manipulating, sampling, formulating, or packaging cell preparations under sterile conditions;
a second working area equipped with one or more instruments for at least one of counting or testing cell preparations; and
a third working area equipped for storing at least one of cell preparations or equipment to be used within the first unit.

### Claim 3 (depends on 1)

The facility of claim 1 further comprising a fifth unit positioned between, and communicatively coupled by means of doors with the first unit and the second unit only.

### Claim 4 (depends on 1)

The facility of claim 1, wherein the first unit comprises walls are made of composite panels comprising:
a water- and air-tight inner surface;
an intermediate layer of a thermally insulating material; and
a shock-resistant, water- and air-tight external surface.

### Claim 5 (depends on 1)

The facility of claim 1, wherein the third unit comprises an HVAC system to exchange air and regulate temperature in the first unit.

### Claim 6 (depends on 5)

The facility of claim 5, wherein the HVAC system is to exchange air and regulate temperature in the second unit.

### Claim 7 (depends on 5)

The facility of claim 5 further comprising a fifth unit, wherein the HVAC system is to exchange air and regulate temperature in the fifth unit.

### Claim 8 (depends on 2)

The facility of claim 2 further comprising one or more instruments for at least one of acquiring, monitoring, storing, elaborating, or transmitting data related to at least one of the preparation of Cell-Based Medicinal Product formulations, manipulations made in the facility, and a status of the first unit, the second unit, the third unit, the fourth unit, the first working area, the second working area, the third working area, or equipment in the facility.

### Claim 9 (depends on 1)

The facility of claim 1, wherein the facility is to allow operating according to ISO standards that are applicable to at least one of production, formulation, administration, or medical use of cell-based products.

### Claim 10 (depends on 1)

The facility of claim 1, wherein the first unit is equipped to allow operators to formulate and validate a Cell-Based Medicinal Product comprising at least one of stem or progenitor cells, primary cells, or cells that have been genetically modified.

### Claim 11 (depends on 1)

The facility of claim 1, wherein the fourth unit comprises a truck.

### Claim 12

A method of providing formulations of a Cell-Based Medicinal Product in a site where said formulations are administered to a patient, comprising:
building a unitary structure comprising equipment and working spaces that allow operators to at least one of store, formulate, or validate Cell-Based Medicinal Products according to Good Manufacturing Practices, and assembling said structure with a vehicle for establishing a facility;
providing bulk Cell-Based Medicinal Products that are prepared according to Good Manufacturing Practices;
storing said bulk Cell-Based Medicinal Product preparations within the facility; and
moving the facility to a site where said bulk Cell-Based Medicinal Product preparations are used for producing and validating formulations of Cell-Based Medicinal Product within said facility, and where said formulations are administered to a patient.
